drugset
drugset / Trial / NCT00002725

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002725 ↗

Phase 2 Completed 35 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of bryostatin-1 in treating patients with recurrent non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Timeline

Start
1996-08
Primary completion
2000-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject bryostatin 1 Small molecule — —

Indications

lymphoma